What iPrescribe changed

• The number of "Annual Prescriptions" displayed in the social proof section decreased from 128 million to 77 million.

The company significantly reduced its reported volume of annual prescriptions. This could reflect a shift in how they calculate data, a change in their network activity, or a correction to previously overstated marketing claims.

• Added "Controlled Substance Prescribing in Multiple States" as a feature for the Practice plan ($50/month).
• Updated the Practice plan description to explicitly mention multi-state prescribing support.
• Updated the annual prescription count statistic from 158 million down to 128 million.
• Fixed minor punctuation in the Enterprise plan description.

Providers who work in multiple states or live near state lines often face legal hurdles when prescribing controlled substances. By adding this to their mid-tier plan, iPrescribe is targeting larger practices and telehealth providers who need to manage complex state-by-state regulations.

• The "Annual Prescriptions" statistic was updated from 180 million to 158 million.

The company reduced its reported annual prescription volume by 22 million. This could indicate a shift in how they calculate data, a loss in market share, or a move toward more conservative and accurate reporting to maintain trust with medical providers.